Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,121 - 1,140 results of 27,058 for search '(( via ((a decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.65s Refine Results
  1. 1121
    Three-dimensional (3D) Collagen Type I gel formula (5 mg/mL).

    Three-dimensional (3D) Collagen Type I gel formula (5 mg/mL). by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 1122
    Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs).

    Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 1123
    TUNEL staining.

    TUNEL staining. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 1124
    Safranin O and toluidine blue histology.

    Safranin O and toluidine blue histology. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 1125
    Experimental outline.

    Experimental outline. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 1126
    Cytotoxicity and total glycosaminoglycan (GAG) content.

    Cytotoxicity and total glycosaminoglycan (GAG) content. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 1127
    Gross photography and construct weight for initial chondrogenic screening.

    Gross photography and construct weight for initial chondrogenic screening. by Melissa A. MacIver (12850566)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 1128
    Image_8_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_8_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  9. 1129
    Image_7_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_7_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  10. 1130
    Image_4_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_4_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  11. 1131
    Image_6_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_6_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  12. 1132
    Image_5_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_5_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  13. 1133
    Image_10_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_10_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  14. 1134
    Image_1_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_1_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  15. 1135
    Image_2_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_2_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  16. 1136
    Image_3_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_3_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  17. 1137
    Image_9_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF

    Image_9_Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease.TIF by Mei-Fang Liu (5966561)

    Published 2018
    “…The upregulation of BDNF is mainly concerned with PI3K and PKC signaling pathways via OX1R. The present study demonstrated that orexin-A exerted neuroprotective effects on MPTP parkinsonian mice, which may imply orexin-A as a potential therapeutic target for PD.…”
    Save to List
    Saved in:
  18. 1138
    Decreased presence of tubulin-GFP at axonal MTs in a pulse chase experiment suggests changes in MT replenishment with age.

    Decreased presence of tubulin-GFP at axonal MTs in a pulse chase experiment suggests changes in MT replenishment with age. by Pilar Okenve-Ramos (18150546)

    Published 2024
    Save to List
    Saved in:
  19. 1139
    The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation

    The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation by Elisabeth Jahny (3692074)

    Published 2017
    “…Especially the loss of apical RAI3 expression represents an independent prognostic parameter for overall survival of patients with pancreatic cancer. Suppression of GPRC5a results in decreased cell growth, proliferation and migration in pancreatic cancer cell lines via a STAT3 modulated pathway, independent from ERK activation.…”
    Save to List
    Saved in:
  20. 1140
    The effect of HBO on the expression of Nrf2, SLC7A11 and GPX4 genes in HT22 cells.

    The effect of HBO on the expression of Nrf2, SLC7A11 and GPX4 genes in HT22 cells. by Chunxia Chen (134627)

    Published 2022
    Save to List
    Saved in:

Search Tools: